COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 478: Articles 4771-4780  | Next

Erythromycin, Retapamulin, Pyridoxine, Folic acid, and Ivermectin dose-dependently inhibit cytopathic effect, Papain-like Protease, and MPRO of SARS-CoV-2
Bello, S. O., Imam, M. U., Bello, M. B., Yunusa, A., Adamu, A. A., Shuaibu, A., Igumbor, E. U., Habib, Z. G., Popoola, M. A., Ochu, C. L., Bello, A. Y., Deeni, Y. Y., Okoye, I.
10.1101/2022.12.28.522082 — Posted: 2022-12-29
Cohort study of fever neonates with confirmed community infection of SARS-CoV-2 Omicron: A study Protocol
Li, J., He, W., Qi, Y., Meng, Y., Peng, X., Hei, M.
10.1101/2022.12.28.22283987 — Posted: 2022-12-29
SARS-CoV-2 accessory proteins ORF3a and ORF7a modulate autophagic flux and Ca2+ homeostasis in yeast
Garrido-Huarte, J. L., Fita-Torro, J., Viana, R., Pascual-Ahuir, A., Proft, M.
10.1101/2022.12.29.522217 — Posted: 2022-12-29
Immunogenicity of COVID-eVax Is Moderately Impacted by Temperature and Molecular Isoforms
D'Alessio, F., Lione, L., Salvatori, E., Bucci, F., Muzi, A., Roscilli, G., Conforti, A., Compagnone, M., Pinto, E., Battistuzzi, G., Aurisicchio, L., Palombo, F.
10.1101/2022.12.29.522202 — Posted: 2022-12-29
A robust deep learning platform to predict CD8+ T-cell epitopes
Lee, C. H.-J., Huh, J., Buckley, P. R., Jang, M. J., Pereira Pinho, M., Fernandes, R., Antanaviciute, A., Simmons, A., Koohy, H.
10.1101/2022.12.29.522182 — Posted: 2022-12-29
New compartment model for COVID-19
Odagaki, T.
10.1101/2022.12.27.22283962 — Posted: 2022-12-29
The Effect of COVID-19 on Distracted Driving: A Survey Study
Javid, R., Sadeghvaziri, E., Jeihani, M.
10.1101/2022.12.26.22283062 — Posted: 2022-12-28
Study protocol: Medium throughput proteomic characterization of children with PIMS-TS, and identification of candidate diagnostic biomarkers.
Roarty, C., Mills, C., Tonry, C., Cosgrove, P., Norman-Bruce, H., Groves, H., Watson, C., Waterfield, T.
10.1101/2022.12.27.22283890 — Posted: 2022-12-28
Viral and host small RNA transcriptome analysis of SARS-CoV-1 and SARS-CoV-2-infected human cells reveals novel viral short RNAs.
Driedonks, T., Nyberg, L., Conte, A., Ma, Z., Pekosz, A., Duban, E., Sültmann, H., Turchinovich, A., Witwer, K.
10.1101/2022.12.27.522023 — Posted: 2022-12-27
The response to BTN62b2 booster doses demonstrates that serum antibodies do not predict the establishment of immune B-cell memory in common variable immune deficiencies
Piano Mortari, E., Pulvirenti, F., Marcellini, V., Terreri, S., Fernandez Salinas, A., Ferrari, S., Di Napoli, G., Guadagnolo, D., Sulco, E., Albano, C., Guercio, M., Di Cecca, S., Milito, C., Garzi, G., Pesce, A. M., Bonanni, L., Sinibaldi, M., Di Cecilia, S., Agrati, C., Quintarelli, C., Zaffina, S., Locatelli, F., Carsetti, R., Quinti, I.
10.1101/2022.12.24.22283775 — Posted: 2022-12-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).